Lynda G Balneaves
Overview
Explore the profile of Lynda G Balneaves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bao T, Lopez G, Crudup T, Lopez A, Paller C, Gowin K, et al.
J Integr Complement Med
. 2024 Aug;
30(10):910-912.
PMID: 39180433
No abstract available.
2.
Carlson L, Tripathy D, Zick S, Balneaves L, Lee R, Greenlee H
J Integr Complement Med
. 2024 Jul;
30(7):596-601.
PMID: 39052420
No abstract available.
3.
Balneaves L, Hammond D, Turner S, Nickel N, Woodgate R, Watling C
J Psychoactive Drugs
. 2024 Jul;
:1-10.
PMID: 38946663
Canada legalized the use of non-medical cannabis in 2018. This study examines youth and young adults' knowledge and perceptions of harms, benefits, and education around cannabis use since legalization. An...
4.
Balneaves L, Alraja A, Thompson G, Penner J, St John P, Scerbo D, et al.
BMC Geriatr
. 2024 May;
24(1):467.
PMID: 38811895
Background: Following the legalization of cannabis in Canada in 2018, people aged 65 + years reported a significant increase in cannabis consumption. Despite limited research with older adults regarding the...
5.
Balneaves L, Brown A, Green M, Prosk E, Rapin L, Monahan-Ellison M, et al.
BMC Med
. 2024 Apr;
22(1):150.
PMID: 38589855
Background: There has been a precipitous decline in authorizations for medical cannabis since non-medical cannabis was legalized in Canada in 2018. This study examines the demographic and health- and medical...
6.
Avery J, Bell J, Baryolay K, Rodin G, Nissim R, Balneaves L
BMC Cancer
. 2024 Mar;
24(1):373.
PMID: 38528488
Background: Participants considering early-phase cancer clinical trials (CTs) need to understand the unique risks and benefits prior to providing informed consent. This qualitative study explored the factors that influence patients'...
7.
Braun I, Bohlke K, Abrams D, Anderson H, Balneaves L, Bar-Sela G, et al.
J Clin Oncol
. 2024 Mar;
42(13):1575-1593.
PMID: 38478773
Purpose: To guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on the medical use of cannabis and cannabinoids, including synthetic cannabinoids and herbal cannabis derivatives; single, purified cannabinoids;...
8.
Ben-Arye E, Mao J, Bruera E, Samuels N, Keshet Y, Lee R, et al.
J Pain Symptom Manage
. 2023 Sep;
67(1):69-76.
PMID: 37769821
Context And Objectives: To explore the feasibility of implementing the joint guideline on integrative medicine for pain management in oncology, published by the Society for Integrative Oncology (SIO) and the...
9.
Balneaves L, Watling C, Strus J, Boscow M, Davis L, Graveline K, et al.
Nurse Educ Today
. 2023 Sep;
130:105955.
PMID: 37677985
Background: With the legalization of non-medical cannabis in Canada, cannabis is commonly used in the community and nurses and nursing students are likely to engage in clinical practice discussions around...
10.
Carlson L, Ismaila N, Addington E, Asher G, Atreya C, Balneaves L, et al.
J Clin Oncol
. 2023 Aug;
41(28):4562-4591.
PMID: 37582238
Purpose: To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer. Methods: The Society for Integrative Oncology and...